Active Biotech
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
ACTI | ST
Overview
Corporate Details
- ISIN(s):
- SE0001137985 (+2 more)
- LEI:
- 549300OJ44CLMRU8YE43
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Active Biotech is a biotechnology company focused on developing pharmaceutical products for medical areas where the immune system is significant, primarily cancer and inflammatory diseases. The company leverages its portfolio of compounds to create novel treatments for specialist indications with high unmet medical need. Its development pipeline includes fully owned projects like tasquinimod for hematological cancers (multiple myeloma, myelofibrosis) and laquinimod for inflammatory eye disorders (non-infectious uveitis). It also has licensed projects, such as naptumomab for solid tumors, which is developed in partnership with NeoTX.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Active Biotech and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-21 08:30 |
Interim Report
|
Swedish | 497.6 KB | |
| 2025-08-21 08:30 |
Interim Report
|
English | 492.9 KB | |
| 2025-06-17 15:15 |
Major Shareholding Notification
|
Swedish | 10.7 KB | |
| 2025-05-28 18:30 |
Post-Annual General Meeting Information
Annual General Meeting of Active Biotech AB
|
English | 76.1 KB | |
| 2025-05-28 18:30 |
Post-Annual General Meeting Information
Årsstämma i Active Biotech AB
|
Swedish | 74.1 KB | |
| 2025-05-08 08:30 |
Quarterly Report
|
Swedish | 406.4 KB | |
| 2025-05-08 08:30 |
Quarterly Report
|
English | 400.9 KB | |
| 2025-05-05 09:00 |
Regulatory News Service
Active Biotech rapporterar positiva top line-resultat från LION-studien om okul…
|
Swedish | 104.6 KB | |
| 2025-05-05 09:00 |
Regulatory News Service
Active Biotech reports positive top-line results from the LION study on ocular …
|
English | 104.9 KB | |
| 2025-04-28 11:00 |
Pre-Annual General Meeting Information
NOTICE OF ANNUAL GENERAL MEETING
|
English | 98.7 KB | |
| 2025-04-28 11:00 |
Pre-Annual General Meeting Information
KALLELSE TILL ÅRSSTÄMMA
|
Swedish | 99.3 KB | |
| 2025-02-13 08:30 |
Annual Report
|
Swedish | 511.4 KB | |
| 2025-02-13 08:30 |
Annual Report
|
English | 506.2 KB | |
| 2025-01-31 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Active Biotech
|
English | 86.2 KB | |
| 2025-01-31 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Active Biotech
|
Swedish | 86.1 KB |
Automate Your Workflow. Get a real-time feed of all Active Biotech filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Active Biotech via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-10 | Peter Thelin | Other | Other | 164,638,960 | 8,231,948.00 SEK |
| 2024-11-15 | Hans Kolam | Other | Other | 19,800 | 990.00 SEK |
| 2022-09-05 | Aleksandar Danilovski | Other | Buy | 26,672 | 26,672.00 SEK |
| 2022-04-22 | Helen Tuvesson Andersson | Other | Buy | 2,665 | 3,102.86 SEK |
| 2022-04-21 | Helen Tuvesson Andersson | Other | Buy | 37,335 | 41,767.60 SEK |
| 2021-06-17 | Aleksandar Danilovski | Other | Buy | 40,000 | 60,000.00 SEK |
| 2021-06-01 | Michael Shalmi | Other | Buy | 175,000 | 259,437.50 SEK |
| 2021-04-27 | Helen Tuvesson Andersson | Other | Buy | 10,411 | 16,657.60 SEK |
| 2021-04-27 | Helena Eriksson | Other | Buy | 10,000 | 14,460.00 SEK |
| 2021-04-27 | Helen Tuvesson Andersson | Other | Buy | 1,041 | 1,665.60 SEK |
